TENNCARE PRIOR AUTHORIZATION APPROVED FOR 80% OF PHYSICIANS
TENNCARE PRIOR AUTHORIZATION APPROVED FOR 80% OF PHYSICIANS who reported having sought prior approval for a drug not included on the TermCare formulary, according to a Pfizer-supported phone survey of 200 TermCare doctors. The survey was commissioned by the Andrew Jackson Institute, which describes itself as a "nonpartisan public policy think tank focused on Tennessee state issues," and conducted by Yankelovich Partners. "Funding was provided by Pfizer," the institute reported.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth